BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND TG, Thyroglobulin AND Prognosis
73 results:

  • 1. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
    Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
    Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Potential Role of Zinc Finger 365
    Ghadamgahi SR; Hosseinzadeh L; Ardalan Khales S; Nassiri M; Alidoust M; Etemadrezaei S; Khorshid Shamshiri A; Homaei Shandiz F; Pasdar A; Afzaljavan F
    Iran J Med Sci; 2023 Nov; 48(6):551-562. PubMed ID: 38094285
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Predictive risk factors for distant metastasis in pediatric differentiated thyroid cancer from Saudi Arabia.
    Parvathareddy SK; Siraj AK; Annaiyappanaidu P; Siraj N; Al-Rasheed M; Al-Haqawi W; Qadri Z; Siddiqui K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Front Endocrinol (Lausanne); 2023; 14():1228049. PubMed ID: 37867506
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nomogram for predicting the prognosis of metastatic colorectal cancer patients treated with anti-PD1 therapy based on serum lipids analysis.
    Xiao B; Ouyang H; Gulizeba H; Fu H; Wang Z; Huang Y
    Cancer Immunol Immunother; 2023 Nov; 72(11):3683-3692. PubMed ID: 37589756
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Assessment of plasma amino acids, purines, tricarboxylic acid cycle metabolites, and lipids levels in NSCLC patients based on LC-MS/MS quantification.
    Cang S; Liu R; Mu K; Tang Q; Cui H; Bi K; Zhang Y; Li Q
    J Pharm Biomed Anal; 2022 Nov; 221():114990. PubMed ID: 36208488
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Plasma lipid-based machine learning models provides a potential diagnostic tool for colorectal cancer patients.
    Yang C; Zhou S; Zhu J; Sheng H; Mao W; Fu Z; Chen Z
    Clin Chim Acta; 2022 Nov; 536():191-199. PubMed ID: 36191612
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Preoperative Serum Triglyceride to High-Density Lipoprotein Cholesterol Ratio Can Predict prognosis in Non-Small Cell lung cancer: A Multicenter Retrospective Cohort Study.
    Li J; Ma C; Yuan X; Wang X; Li N; Yu R; Liao H
    Curr Oncol; 2022 Aug; 29(9):6125-6136. PubMed ID: 36135050
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic significance of TG/HDL-C and non-HDL-C/HDL-C ratios in patients with non-small cell lung cancer: a retrospective study.
    Kong L; Zhao Q; Han Z; Xue W; Hu Z; Niu Z; Duan G
    J Int Med Res; 2022 Aug; 50(8):3000605221117211. PubMed ID: 35949158
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Significance of the Expression of TC and TG Levels in the Initial Diagnosis and Treatment of SCLC Patients and Their Tie-In with prognosis.
    Chen Q; Tang F; Zhang H
    Contrast Media Mol Imaging; 2022; 2022():1297072. PubMed ID: 35845728
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Lipid profiling in malignant mesothelioma reveals promising signatures for diagnosis and prognosis: A plasma-based LC-MS lipidomics study.
    Chen Z; Song S; Yang C; Dai Z; Gao Y; Li N; Zhu J; Mao W; Liu J
    Clin Chim Acta; 2022 Jan; 524():34-42. PubMed ID: 34843704
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic significance of preoperative serum triglycerides and high-density lipoproteins cholesterol in patients with non-small cell lung cancer: a retrospective study.
    Ma C; Wang X; Guo J; Liu P
    Lipids Health Dis; 2021 Oct; 20(1):69. PubMed ID: 34598703
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Effect of serum lipid level on prognosis of patients with small cell lung cancer at the initial treatment].
    Cui YN; Gao Q; Zhu SS; Jin HF
    Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):318-323. PubMed ID: 33752312
    [No Abstract]    [Full Text] [Related]  

  • 13. Genetic Polymorphisms in Activating Transcription Factor 3 Binding Site and the prognosis of Early-Stage Non-Small Cell lung cancer.
    Kang HG; Park JE; Lee SY; Choi JE; Do SK; Hong MJ; Lee JH; Jeong JY; Do YW; Lee EB; Shin KM; Lee WK; Choi SH; Lee YH; Seo HW; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
    Oncology; 2021; 99(5):336-344. PubMed ID: 33626541
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A cutoff thyroglobulin value suggestive of distant metastases in differentiated thyroid cancer patients.
    Couto JS; Almeida MFO; Trindade VCG; Marone MMS; Scalissi NM; Cury AN; Ferraz C; Padovani RP
    Braz J Med Biol Res; 2020; 53(11):e9781. PubMed ID: 33053096
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Unusual metastases from differentiated thyroid cancers: A multicenter study in Korea.
    Yoon JH; Jeon MJ; Kim M; Hong AR; Kim HK; Shin DY; Kim BH; Kim WB; Shong YK; Kang HC
    PLoS One; 2020; 15(8):e0238207. PubMed ID: 32841270
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Unusual metastases from differentiated thyroid carcinoma: analysis of 36 cases.
    Zunino A; Pitoia F; Faure E; Reyes A; Sala M; Sklate R; Ilera V; Califano I;
    Endocrine; 2019 Sep; 65(3):630-636. PubMed ID: 31327159
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Association of MDM2 gene SNP 309 polymorphism and human non-small cell lung cancer susceptibility: A meta-analysis.
    Luan L; Wang H; Zhao B; Wang F; Shi J; Xu X
    Pathol Res Pract; 2019 Sep; 215(9):152538. PubMed ID: 31326197
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical outcomes and prognostic factors in patients with no less than three distant organ system metastases from differentiated thyroid carcinoma.
    Zhang XY; Sun JW; Qiu ZL; Wang Y; Chen XY; Zhao JH; Luo QY
    Endocrine; 2019 Nov; 66(2):254-265. PubMed ID: 31317522
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Progression free survival related to
    Zhu X; Wu S; Yuan X; Wang H; Ma C
    Hell J Nucl Med; 2019; 22(2):123-130. PubMed ID: 31273354
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clear Cell Variant of Papillary Thyroid Carcinoma With Associated Anaplastic Thyroid Carcinoma: Description of an Extraordinary Case.
    Juhlin CC; Höög A
    Int J Surg Pathol; 2019 Sep; 27(6):658-663. PubMed ID: 30931661
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.